Immunovant, Inc. (IMVT)
25.98
-1.37
(-5.01%)
USD |
NASDAQ |
Jan 15, 16:00
25.98
0.00 (0.00%)
After-Hours: 20:00
Immunovant SG&A Expense (TTM): 83.49M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Revvity, Inc. | 984.49M |
| Viridian Therapeutics, Inc. | 77.23M |
| Perspective Therapeutics, Inc. | 31.53M |
| Electromed, Inc. | 40.21M |
| InfuSystem Holdings, Inc. | 66.30M |